threonine has been researched along with Vascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, DH; Jo, I; Lee, HJ; Lee, JY; Park, JH; Seo, J; Sung, MS; Won, KJ | 1 |
| Chiasson, VL; Mitchell, BM; Quinn, MA; Young, KJ | 1 |
2 other study(ies) available for threonine and Vascular Diseases
| Article | Year |
|---|---|
Citron Rho-interacting kinase mediates arsenite-induced decrease in endothelial nitric oxide synthase activity by increasing phosphorylation at threonine 497: Mechanism underlying arsenite-induced vascular dysfunction.
Topics: Animals; Arsenites; Cattle; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Endothelial Cells; Intracellular Signaling Peptides and Proteins; Isoquinolines; Male; Nitric Oxide Synthase Type III; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Sulfonamides; Threonine; Vascular Diseases; Vasodilation | 2016 |
Protein kinase CbetaII-mediated phosphorylation of endothelial nitric oxide synthase threonine 495 mediates the endothelial dysfunction induced by FK506 (tacrolimus).
Topics: Animals; Aorta; Cells, Cultured; Endothelial Cells; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; Phosphorylation; Protein Kinase C; Protein Kinase C beta; Rats; Tacrolimus; Threonine; Vascular Diseases | 2011 |